Targets — browse / sort / filter (view)
Data license: CC BY 4.0 · Data source: apt-scout automated curation pipeline (E. Dohi, NCNP) — values harvested from public databases; raw source stored per target
- id
- UniProt accession (human). Links to uniprot.org.
- gene_symbol
- Gene symbol (e.g. ITGB3).
- protein_name
- Protein name (UniProt).
- tier
- Tier 1 = PDB-anchored; Tier 1.5 = AlphaFold-confident.
- has_structure
- 1 if the target protein has a reported experimental 3D structure (PDB). This is the CORE requirement the aptamer-Kd layer is built around — filter to 1 for the structure-backed set.
- evidence_priority
- DETERMINISTIC, reproducible prioritisation (0-1) computed at build time from real harvested columns: 0.35*experimental-structure(PDB=1 / AlphaFold-only=0.3) + 0.30*Open-Targets-top-disease-score + 0.20*PREDICTED-surface-accessibility(A_surface=1) + 0.15*EV-detection(EV-Map). A transparent ranking AID, not a validation; the surface/EV terms are PREDICTIONS/DETECTIONS, not measured EV-surface exposure. Recomputable exactly from this DB.
- has_activation_state_pdb_pair
- 1 if a curated ACTIVE/INACTIVE PDB pair exists (only 11 targets).
- in_cev_map
- Detected in the EV-Map plasma-EV dataset (Rai & Greening 2025, Nat Cell Biol, 10.1038/s41556-025-01795-7) = 3,422 apt-scout targets (broad detected proteome). The EV-Map CONSERVED EV proteome is 182 proteins (42 non-EV); apt-scout matches 104 of these conserved EV-hallmark proteins as targets by gene (the other 78 are not apt-scout targets). Use the ev_hallmark_targets query for that subset. IMPORTANT: EV-Map detection means the protein is EV CARGO (present in the vesicle) — it does NOT mean surface-exposed. Rai & Greening 2025 run a separate membrane-impermeant biotinylation assay giving a 151-protein SURFACEOME, and show the conserved SDCBP/syntenin is luminal (not surface-accessible). For genuine EV-surface accessibility use that 151-protein set, not EV-Map presence.
- has_known_aptamer
- 1 if PubMed '(gene) AND (aptamer OR SELEX)' returned any hit (KEYWORD co-mention, includes false positives — NOT a verified aptamer). For verified aptamers with Kd, see the Binding-affinities (v_kd) layer.
- opentargets_top_disease_score
- Open Targets association score (0-1).
- aptamer_count_pubmed
- Number of PubMed hits for (this protein) AND (aptamer OR SELEX). Keyword co-occurrence — verify each (many co-mention without a real aptamer).
- aptamer_pmids
- The actual PubMed IDs behind the aptamer evidence — click each to read the paper. This is the source of the 'has aptamer' claim.
- surface_class
- PREDICTED membrane topology (HPA-derived, not a measurement): A_surface = integral/ecto cell-surface (predicted EV-surface accessible); A2_pm_peripheral = plasma-membrane cytoplasmic-leaflet (SRC/LYN/RHOA, predicted not reachable); A_assoc = secreted/corona; B_cargo = luminal cargo; unknown = no HPA localization. Lipid asymmetry can partially flip (PS via scramblase); confirm by protease-protection / intact-EV surface labelling. See v_surface_targets.
177 rows where has_known_aptamer = 0, surface_class = "A_assoc" and tier = "Tier 1.5" sorted by evidence_priority descending
This data as json, CSV (advanced)
Suggested facets: pdb_count_total
tier 1
- Tier 1.5 · 177 ✖
surface_class 1
- A_assoc · 177 ✖
has_known_aptamer 1
- - · 177 ✖
has_activation_state_pdb_pair 1
- 0 177
| id | gene_symbol | protein_name | tier | evidence_priority ▲ | has_structure | surface_class | pdb_count_total | alphafold_mean_pLDDT | has_cryoEM | has_activation_state_pdb_pair | activation_state_pdb_active | activation_state_pdb_inactive | has_known_aptamer | aptamer_count_pubmed | aptamer_pmids | in_cev_map | opentargets_top_disease_name | opentargets_top_disease_score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P02462 | COL4A1 | Collagen alpha-1(IV) chain | Tier 1.5 | 0.854 | 1 | A_assoc | 4 | 48.47 | 0 | 0 | 0 | 0 | 1 | brain small vessel disease 1 with or without ocular anomalies | 0.84655287380359 | |||
| P04180 | LCAT | Phosphatidylcholine-sterol acyltransferase | Tier 1.5 | 0.848 | 1 | A_assoc | 7 | 86.75 | 1 | 0 | 0 | 0 | 1 | Fish-eye disease | 0.8273460309828392 | |||
| Q15582 | TGFBI | Transforming growth factor-beta-induced protein ig-h3 | Tier 1.5 | 0.847 | 1 | A_assoc | 10 | 90.25 | 1 | 0 | 0 | 0 | 1 | lattice corneal dystrophy type I | 0.8242841141270143 | |||
| P07942 | LAMB1 | Laminin subunit beta-1 | Tier 1.5 | 0.84 | 1 | A_assoc | 3 | 76.69 | 1 | 0 | 0 | 0 | 1 | cobblestone lissencephaly without muscular or ocular involvement | 0.8016665947624902 | |||
| P22105 | TNXB | Tenascin-X | Tier 1.5 | 0.837 | 1 | A_assoc | 3 | 87.81 | 0 | 0 | 0 | 0 | 1 | Ehlers-Danlos syndrome due to tenascin-X deficiency | 0.7916412481554758 | |||
| P35858 | IGFALS | Insulin-like growth factor-binding protein complex acid labile subunit | Tier 1.5 | 0.833 | 1 | A_assoc | 1 | 90.56 | 1 | 0 | 0 | 0 | 1 | Reduced insulin like growth factor binding protein acid labile subunit concentration | 0.7760522769257892 | |||
| O15230 | LAMA5 | Laminin subunit alpha-5 | Tier 1.5 | 0.828 | 1 | A_assoc | 2 | 79.12 | 1 | 0 | 0 | 0 | 1 | nephrotic syndrome, IIa 26 | 0.7594872666460903 | |||
| P08572 | COL4A2 | Collagen alpha-2(IV) chain | Tier 1.5 | 0.819 | 1 | A_assoc | 4 | 47.25 | 0 | 0 | 0 | 0 | 1 | porencephaly 2 | 0.7294975109351518 | |||
| O60568 | PLOD3 | Multifunctional procollagen lysine hydroxylase and glycosyltransferase LH3 | Tier 1.5 | 0.815 | 1 | A_assoc | 18 | 91.38 | 1 | 0 | 0 | 0 | 1 | bone fragility with contractures, arterial rupture, and deafness | 0.7159150369336311 | |||
| Q9Y6C2 | EMILIN1 | EMILIN-1 | Tier 1.5 | 0.786 | 1 | A_assoc | 2 | 62.91 | 0 | 0 | 0 | 0 | 1 | arterial tortuosity-bone fragility syndrome | 0.6185329512431467 | |||
| P49767 | VEGFC | Vascular endothelial growth factor C | Tier 1.5 | 0.785 | 1 | A_assoc | 4 | 73.19 | 0 | 0 | 0 | 0 | 1 | Milroy disease | 0.6170524106764851 | |||
| O00622 | CCN1 | CCN family member 1 | Tier 1.5 | 0.765 | 1 | A_assoc | 2 | 73.12 | 0 | 0 | 0 | 0 | 1 | Abnormality of the skeletal system | 0.5505331194769112 | |||
| Q68CZ2 | TNS3 | Tensin-3 | Tier 1.5 | 0.762 | 1 | A_assoc | 1 | 56.81 | 0 | 0 | 0 | 0 | 1 | neurodegenerative disease | 0.539772721274482 | |||
| Q9Y3B8 | REXO2 | Oligoribonuclease, mitochondrial | Tier 1.5 | 0.754 | 1 | A_assoc | 10 | 88.19 | 0 | 0 | 0 | 0 | 1 | neurodegenerative disease | 0.5134178677464454 | |||
| P36980 | CFHR2 | Complement factor H-related protein 2 | Tier 1.5 | 0.753 | 1 | A_assoc | 4 | 90.62 | 0 | 0 | 0 | 0 | 1 | age-related macular degeneration | 0.5100732932209376 | |||
| Q13177 | PAK2 | Serine/threonine-protein kinase PAK 2 | Tier 1.5 | 0.736 | 1 | A_assoc | 5 | 74.62 | 0 | 0 | 0 | 0 | 1 | Knobloch syndrome | 0.45371318009439854 | |||
| Q13625 | TP53BP2 | Apoptosis-stimulating of p53 protein 2 | Tier 1.5 | 0.735 | 1 | A_assoc | 6 | 58.97 | 0 | 0 | 0 | 0 | 1 | neurodegenerative disease | 0.4484066399496438 | |||
| Q9UKU9 | ANGPTL2 | Angiopoietin-related protein 2 | Tier 1.5 | 0.727 | 1 | A_assoc | 1 | 78.19 | 0 | 0 | 0 | 0 | 1 | Abnormality of the skeletal system | 0.4235882639081519 | |||
| Q96SL4 | GPX7 | Glutathione peroxidase 7 | Tier 1.5 | 0.721 | 1 | A_assoc | 1 | 92.69 | 0 | 0 | 0 | 0 | 1 | Abnormality of the skeletal system | 0.40349356855524837 | |||
| Q16627 | CCL14 | C-C motif chemokine 14 | Tier 1.5 | 0.711 | 1 | A_assoc | 2 | 85.38 | 0 | 0 | 0 | 0 | 1 | neurodegenerative disease | 0.37013422446672883 | |||
| O95970 | LGI1 | Leucine-rich glioma-inactivated protein 1 | Tier 1.5 | 0.697 | 1 | A_assoc | 9 | 92.56 | 1 | 0 | 0 | 0 | 0 | autosomal dominant epilepsy with auditory features | 0.8225657483127345 | |||
| Q8WUP2 | FBLIM1 | Filamin-binding LIM protein 1 | Tier 1.5 | 0.687 | 1 | A_assoc | 3 | 66.44 | 0 | 0 | 0 | 0 | 1 | COVID-19 | 0.28975781420803737 | |||
| P29120 | PCSK1 | Neuroendocrine convertase 1 | Tier 1.5 | 0.682 | 1 | A_assoc | 3 | 82.5 | 0 | 0 | 0 | 0 | 0 | obesity due to prohormone convertase I deficiency | 0.773875795833803 | |||
| P19876 | CXCL3 | C-X-C motif chemokine 3 | Tier 1.5 | 0.679 | 1 | A_assoc | 2 | 81.88 | 1 | 0 | 0 | 0 | 1 | neurodegenerative disease | 0.26311734927710556 | |||
| P16112 | ACAN | Aggrecan core protein | Tier 1.5 | 0.677 | 1 | A_assoc | 4 | 51.91 | 0 | 0 | 0 | 0 | 0 | Familial osteochondritis dissecans | 0.7558487616449627 | |||
| P55789 | GFER | FAD-linked sulfhydryl oxidase ALR | Tier 1.5 | 0.677 | 1 | A_assoc | 7 | 76.88 | 0 | 0 | 0 | 0 | 0 | congenital cataract-progressive muscular hypotonia-hearing loss-developmental delay syndrome | 0.7556346526616893 | |||
| P19875 | CXCL2 | C-X-C motif chemokine 2 | Tier 1.5 | 0.674 | 1 | A_assoc | 4 | 81.62 | 1 | 0 | 0 | 0 | 1 | neurodegenerative disease | 0.24624512698601778 | |||
| Q12794 | HYAL1 | Hyaluronidase-1 | Tier 1.5 | 0.672 | 1 | A_assoc | 1 | 94.0 | 0 | 0 | 0 | 0 | 0 | Hyaluronidase deficiency | 0.7412407206736383 | |||
| Q92752 | TNR | Tenascin-R | Tier 1.5 | 0.672 | 1 | A_assoc | 2 | 78.5 | 0 | 0 | 0 | 0 | 0 | neurodevelopmental disorder, nonprogressive, with spasticity and transient opisthotonus | 0.7403484347367364 | |||
| P11686 | SFTPC | Surfactant protein C | Tier 1.5 | 0.663 | 1 | A_assoc | 3 | 70.06 | 0 | 0 | 0 | 0 | 0 | Congenital pulmonary alveolar proteinosis | 0.7110128683619542 | |||
| O43897 | TLL1 | Tier 1.5 | 0.662 | 1 | A_assoc | 1 | 80.31 | 0 | 0 | 0 | 0 | 0 | atrial heart septal defect | 0.7050140477090344 | ||||
| P27352 | CBLIF | Cobalamin binding intrinsic factor | Tier 1.5 | 0.655 | 1 | A_assoc | 2 | 90.5 | 0 | 0 | 0 | 0 | 0 | hereditary intrinsic factor deficiency | 0.683930100359911 | |||
| O95631 | NTN1 | Netrin-1 | Tier 1.5 | 0.648 | 1 | A_assoc | 5 | 88.5 | 1 | 0 | 0 | 0 | 0 | mirror movements 4 | 0.6611393488240481 | |||
| Q9NWU2 | GID8 | Glucose-induced degradation protein 8 homolog | Tier 1.5 | 0.631 | 1 | A_assoc | 1 | 91.94 | 1 | 0 | 0 | 0 | 1 | Abnormality of the skeletal system | 0.10187555420552867 | |||
| Q15818 | NPTX1 | Neuronal pentraxin-1 | Tier 1.5 | 0.628 | 1 | A_assoc | 1 | 75.75 | 0 | 0 | 0 | 0 | 0 | spinocerebellar ataxia 50 | 0.5937598292127286 | |||
| P07098 | LIPF | Gastric triacylglycerol lipase | Tier 1.5 | 0.626 | 1 | A_assoc | 1 | 89.75 | 0 | 0 | 0 | 0 | 0 | obesity | 0.5864662753480862 | |||
| Q6IBW4 | NCAPH2 | Condensin-2 complex subunit H2 | Tier 1.5 | 0.62 | 1 | A_assoc | 1 | 62.41 | 1 | 0 | 0 | 0 | 0 | cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 1 | 0.5674645203025676 | |||
| O00175 | CCL24 | C-C motif chemokine 24 | Tier 1.5 | 0.613 | 1 | A_assoc | 2 | 82.12 | 0 | 0 | 0 | 0 | 0 | Iron deficiency anemia | 0.5428194908352497 | |||
| P35556 | FBN2 | Fibrillin-2 | Tier 1.5 | 0.612 | 0 | A_assoc | 0 | 68.38 | 0 | 0 | 0 | 0 | 1 | congenital contractural arachnodactyly | 0.8556257369085999 | |||
| P55268 | LAMB2 | Laminin subunit beta-2 | Tier 1.5 | 0.598 | 0 | A_assoc | 0 | 75.62 | 0 | 0 | 0 | 0 | 1 | LAMB2-related infantile-onset nephrotic syndrome | 0.8098669226688374 | |||
| Q13751 | LAMB3 | Laminin subunit beta-3 | Tier 1.5 | 0.596 | 0 | A_assoc | 0 | 78.25 | 0 | 0 | 0 | 0 | 1 | junctional epidermolysis bullosa, non-Herlitz type | 0.8026933429516515 | |||
| Q9UKX2 | MYH2 | Myosin-2 | Tier 1.5 | 0.593 | 0 | A_assoc | 0 | 73.31 | 0 | 0 | 0 | 0 | 1 | myopathy, proximal, and ophthalmoplegia | 0.7931369221020983 | |||
| Q9ULL8 | SHROOM4 | Protein Shroom4 | Tier 1.5 | 0.593 | 1 | A_assoc | 1 | 47.09 | 0 | 0 | 0 | 0 | 0 | X-linked intellectual disability, Stocco dos Santos type | 0.4759334640315342 | |||
| Q6KF10 | GDF6 | Growth/differentiation factor 6 | Tier 1.5 | 0.588 | 0 | A_assoc | 0 | 70.06 | 0 | 0 | 0 | 0 | 1 | Klippel-Feil syndrome 1, autosomal dominant | 0.7775817215750842 | |||
| P28039 | AOAH | Acyloxyacyl hydrolase | Tier 1.5 | 0.585 | 1 | A_assoc | 2 | 90.38 | 0 | 0 | 0 | 0 | 0 | type 2 diabetes mellitus | 0.4486206035972812 | |||
| P11684 | SCGB1A1 | Uteroglobin | Tier 1.5 | 0.581 | 1 | A_assoc | 2 | 88.56 | 0 | 0 | 0 | 0 | 0 | chronic obstructive pulmonary disease | 0.43588476688573263 | |||
| P05997 | COL5A2 | Collagen alpha-2(V) chain | Tier 1.5 | 0.579 | 0 | A_assoc | 0 | 52.0 | 0 | 0 | 0 | 0 | 1 | Ehlers-Danlos syndrome, classic type, 2 | 0.7460629361318855 | |||
| Q63HQ2 | EGFLAM | Pikachurin | Tier 1.5 | 0.574 | 1 | A_assoc | 3 | 80.56 | 1 | 0 | 0 | 0 | 0 | mathematical ability | 0.41387833248094535 | |||
| Q13007 | IL24 | Interleukin-24 | Tier 1.5 | 0.572 | 1 | A_assoc | 2 | 83.38 | 0 | 0 | 0 | 0 | 0 | clear cell renal carcinoma | 0.4074364261926763 | |||
| Q96A83 | COL26A1 | Collagen alpha-1(XXVI) chain | Tier 1.5 | 0.568 | 1 | A_assoc | 6 | 59.66 | 0 | 0 | 0 | 0 | 0 | Inguinal hernia | 0.39338285604421097 |
Advanced export
JSON shape: default, array, newline-delimited
CREATE VIEW v_targets AS
SELECT f.id, n.gene_symbol, n.protein_name, tg.tier,
-- evidence_priority: DETERMINISTIC, reproducible from real DB columns (no LLM).
-- Transparent weights over harvested evidence: structure 0.35, disease importance
-- 0.30 (Open Targets top-disease score), PREDICTED surface accessibility 0.20,
-- EV detection 0.15. A heuristic ranking aid, not a validation; surface/EV terms
-- are predictions/detections, NOT measured EV-surface exposure.
ROUND(
0.35*(CASE WHEN CAST(COALESCE(f.pdb_count_total,'0') AS INTEGER)>0 THEN 1.0
WHEN CAST(COALESCE(NULLIF(f.alphafold_mean_pLDDT,''),'0') AS REAL)>0 THEN 0.3 ELSE 0.0 END)
+ 0.30*MIN(CAST(COALESCE(NULLIF(f.opentargets_top_disease_score,''),'0') AS REAL), 1.0)
+ 0.20*(CASE sc.surface_class WHEN 'A_surface' THEN 1.0 WHEN 'A_assoc' THEN 0.5 WHEN 'A2_pm_peripheral' THEN 0.2 ELSE 0.0 END)
+ 0.15*(CASE WHEN CAST(COALESCE(f.in_cev_map,0) AS INTEGER)=1 THEN 1.0 ELSE 0.0 END)
, 3) AS evidence_priority,
(CASE WHEN CAST(COALESCE(f.pdb_count_total,'0') AS INTEGER)>0 THEN 1 ELSE 0 END) AS has_structure,
sc.surface_class,
f.pdb_count_total, f.alphafold_mean_pLDDT, f.has_cryoEM,
f.has_activation_state_pdb_pair, f.activation_state_pdb_active, f.activation_state_pdb_inactive,
f.has_known_aptamer, f.aptamer_count_pubmed, ap.aptamer_pmids,
f.in_cev_map, f.opentargets_top_disease_name, f.opentargets_top_disease_score
FROM v_target_full f
LEFT JOIN target_names n ON n.target_id=f.id
LEFT JOIN targets tg ON tg.id=f.id
LEFT JOIN target_aptamer_pmids ap ON ap.target_id=f.id
LEFT JOIN membrane_surface_class sc ON sc.target_id=f.id;